96 related articles for article (PubMed ID: 3651856)
1. [Relation between indicators of respiratory tract patency and intrapulmonary distribution of ventilation in patients with chronic obstructive bronchopulmonary disease after combined administration of aminophylline and fenoterol].
Mayer M; Dúbrava I; Strmen J; Dúbravová H
Bratisl Lek Listy; 1987 May; 87(5):606-15. PubMed ID: 3651856
[No Abstract] [Full Text] [Related]
2. [Bronchodilation effects of aminophylline, fenoterol and their combination].
Mayer M; Dúbravová H
Bratisl Lek Listy; 1982 Sep; 78(3):323-33. PubMed ID: 7139383
[No Abstract] [Full Text] [Related]
3. Oral sustained-release aminophylline and bronchodilator response to inhaled fenoterol in patients with chronic airflow obstruction.
Carpentiere G; Marino S; Castello F; Zarcone P; Cipolla G; Baldanza C
Chest; 1985 Oct; 88(4):576-8. PubMed ID: 4042711
[TBL] [Abstract][Full Text] [Related]
4. [Basic medication of chronic obstructive lung disease with berodual].
Melent'eva EM
Klin Med (Mosk); 1999; 77(7):47-8. PubMed ID: 10483166
[No Abstract] [Full Text] [Related]
5. [The effect of long-term oral administration of a bronchodilator, a sustained-release aminophylline preparation, on pulmonary function (author's transl)].
Wiessmann KJ
Dtsch Med Wochenschr; 1975 Nov; 100(48):2482-6. PubMed ID: 1201724
[TBL] [Abstract][Full Text] [Related]
6. [(Whole body plethysmographic studies on the bronchospasmolytic effect of injectabls drugs. Comparison of aminophylline, diprophylline and hexoprenaline)].
Kaik G
Int J Clin Pharmacol Biopharm; 1976 Oct; 14(3):177-85. PubMed ID: 137218
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of chronic obstructive pulmonary disease with orally administered aminophylline].
Zhong NS
Zhonghua Jie He He Hu Xi Za Zhi; 1988 Oct; 11(5):265-8, 317-8. PubMed ID: 3233685
[No Abstract] [Full Text] [Related]
8. Aminophylline blood levels with concomitant erythromycin therapy in relapsed chronic obstructive lung disease.
Vercelloni M; Cogo R; Albertini A; Granata M; Rosaschino F
J Int Med Res; 1986; 14(3):131-6. PubMed ID: 3721053
[TBL] [Abstract][Full Text] [Related]
9. Nebulized fenoterol and i.v. aminophylline in acute severe asthma.
Bowler SD; Mitchell CA; Armstrong JG; Scicchitano R
Eur J Respir Dis; 1987 May; 70(5):280-3. PubMed ID: 3609188
[TBL] [Abstract][Full Text] [Related]
10. Effect of intravenously administered aminophylline on ventilation/perfusion inequality during recovery from exacerbations of chronic obstructive pulmonary disease.
Barberá JA; Reyes A; Roca J; Montserrat JM; Wagner PD; Rodríguez-Roisin R
Am Rev Respir Dis; 1992 Jun; 145(6):1328-33. PubMed ID: 1595998
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of severe bronchial asthma and status asthmaticus with intravenous fenoterol].
Baur X
Dtsch Med Wochenschr; 1988 May; 113(19):763-6. PubMed ID: 3366075
[TBL] [Abstract][Full Text] [Related]
12. [Pattern of breathing and obstruction pressure in patients with airway obstruction after inhalation of bronchodilators].
Franczuk M; Radwan L; Maszczyk Z; Kazimierczak A; Kuś J; Koziorowski A; Kowalski J
Pneumonol Alergol Pol; 1997; 65(7-8):457-64. PubMed ID: 9410281
[TBL] [Abstract][Full Text] [Related]
13. Comparison of standard- and sustained-release theophylline tablets in patients with chronic obstructive pulmonary disease.
Dasta J; Mirtallo JM; Altman M
Am J Hosp Pharm; 1979 May; 36(5):613-7. PubMed ID: 453214
[No Abstract] [Full Text] [Related]
14. Dose-response effects and time course of effects of inhaled fenoterol on respiratory mechanics and arterial oxygen tension in mechanically ventilated patients with chronic airflow obstruction.
Bernasconi M; Brandolese R; Poggi R; Manzin E; Rossi A
Intensive Care Med; 1990; 16(2):108-14. PubMed ID: 2332537
[TBL] [Abstract][Full Text] [Related]
15. [The validation and procedure of inhalation therapy using 2-component aerosols in obstructive bronchopulmonary diseases].
Ivashkin VT; Iakovlev VN; Sinopal'nikov AI; Antokhin EA
Ter Arkh; 1993; 65(8):44-9. PubMed ID: 8211802
[No Abstract] [Full Text] [Related]
16. Aminophylline in the outpatient management of decompensated chronic obstructive pulmonary disease.
Murata GH; Gorby MS; Chick TW; Halperin AK
Chest; 1990 Dec; 98(6):1346-50. PubMed ID: 2123149
[TBL] [Abstract][Full Text] [Related]
17. The effects of inhaled ipratropium bromide, fenoterol and their combination in COPD patients.
Charoenpan P; Kiatboonsri S; Uswanopakhun P; Vongvivat K; Sulaimanee P
J Med Assoc Thai; 1990 Feb; 73(2):91-5. PubMed ID: 2141057
[TBL] [Abstract][Full Text] [Related]
18. [Use of the preparation Ditek in chronic obstructive lung diseases].
Kakhnovskiĭ IM; Marinin VF; Solomatin AS; Antokhin EA
Sov Med; 1991; (6):53-4. PubMed ID: 1909465
[No Abstract] [Full Text] [Related]
19. [Effects of aerosol oxitropium bromide and fenoterol on maximal exercise capacity in chronic obstructive pulmonary disease and their correlation with air flow during exercise and with parameters of maximal exercise].
Suruda T; Nakamura H; Kobayashi H; Uetani K; Nishio M; Higashimoto Y; Funasako M; Ohata M
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Sep; 31(9):1089-95. PubMed ID: 8255017
[TBL] [Abstract][Full Text] [Related]
20. Inhaled fenoterol-ipratropium bromide in mechanically ventilated patients with chronic obstructive pulmonary disease.
Guerin C; Chevre A; Dessirier P; Poncet T; Becquemin MH; Dequin PF; Le Guellec C; Jacques D; Fournier G
Am J Respir Crit Care Med; 1999 Apr; 159(4 Pt 1):1036-42. PubMed ID: 10194143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
